News + Filings Transactions
|
Easom Eric
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/15/2023 | AN2 Therapeutics, Inc. | | Purchase | Common Stock | 10k | $5.38 | $53.8k | See Footnote | 05/15/2023 |
| 02/23/2023 | AN2 Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 267.6k | $11.99 | $3.2M | | 02/23/2023 |
| 11/14/2022 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 23 | $15.04 | $345.9 | | 11/10/2022 |
| 11/10/2022 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 4.4k | $15.32 | $67.6k | | 11/10/2022 |
| 11/07/2022 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 10.2k | $15.90 | $161.7k | | 11/03/2022 |
| 11/07/2022 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 2k | $16.72 | $34k | | 11/03/2022 |
| 11/04/2022 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 8.8k | $15.80 | $139.5k | | 11/03/2022 |
| 11/03/2022 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 11.1k | $15.67 | $173.7k | | 11/03/2022 |
| 11/03/2022 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 3.1k | $16.02 | $49.4k | | 11/03/2022 |
| 05/12/2022 | AN2 Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 225k | $17.28 | $3.9M | | 05/12/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Common Stock | 4.9k | $0.00 | $0 | | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Series A Convertible Preferred Stock | 4.9k | $0.00 | $0 | | 03/29/2022 |
|